Tower View Investment Management & Research LLC Boosts Stock Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Tower View Investment Management & Research LLC raised its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 2.4% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 3,094 shares of the medical equipment provider’s stock after purchasing an additional 73 shares during the period. Tower View Investment Management & Research LLC’s holdings in Intuitive Surgical were worth $1,671,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds also recently bought and sold shares of the company. Manchester Financial Inc. purchased a new position in Intuitive Surgical in the second quarter valued at about $25,000. Advisory Alpha LLC purchased a new position in Intuitive Surgical in the first quarter valued at about $32,000. Nelson Van Denburg & Campbell Wealth Management Group LLC grew its stake in Intuitive Surgical by 733.3% in the second quarter. Nelson Van Denburg & Campbell Wealth Management Group LLC now owns 75 shares of the medical equipment provider’s stock valued at $39,000 after purchasing an additional 66 shares during the last quarter. North Star Investment Management Corp. purchased a new position in Intuitive Surgical in the third quarter valued at about $49,000. Finally, FNY Investment Advisers LLC purchased a new stake in shares of Intuitive Surgical during the second quarter worth about $47,000. Institutional investors own 85.87% of the company’s stock.

Intuitive Surgical stock traded up $5.12 during mid-day trading on Wednesday, reaching $514.12. 328,876 shares of the company were exchanged, compared to its average volume of 711,254. The firm’s 50-day simple moving average is $515.78 and its two-hundred day simple moving average is $518.98. The firm has a market cap of $58.66 billion, a PE ratio of 54.17, a price-to-earnings-growth ratio of 3.88 and a beta of 1.13. Intuitive Surgical, Inc. has a twelve month low of $430.24 and a twelve month high of $589.32.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Thursday, July 18th. The medical equipment provider reported $3.25 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.23 by $1.02. The firm had revenue of $1.10 billion during the quarter, compared to analysts’ expectations of $1.03 billion. Intuitive Surgical had a return on equity of 17.35% and a net margin of 29.95%. Intuitive Surgical’s revenue was up 20.9% on a year-over-year basis. During the same period in the previous year, the firm posted $2.76 earnings per share. Sell-side analysts predict that Intuitive Surgical, Inc. will post 10.12 EPS for the current fiscal year.

A number of equities research analysts have recently weighed in on the company. ValuEngine lowered Intuitive Surgical from a “hold” rating to a “sell” rating in a research note on Friday, July 12th. BidaskClub lowered Intuitive Surgical from a “buy” rating to a “hold” rating in a research note on Wednesday, September 11th. UBS Group set a $560.00 price target on Intuitive Surgical and gave the stock a “hold” rating in a research note on Friday, July 19th. Piper Jaffray Companies lifted their target price on Intuitive Surgical from $610.00 to $633.00 and gave the stock an “overweight” rating in a report on Friday, July 19th. Finally, Canaccord Genuity reaffirmed a “buy” rating and set a $610.00 target price (up previously from $575.00) on shares of Intuitive Surgical in a report on Friday, July 19th. Three research analysts have rated the stock with a sell rating, four have issued a hold rating and nine have assigned a buy rating to the company. The stock presently has a consensus rating of “Hold” and a consensus target price of $575.33.

In other Intuitive Surgical news, Director Lonnie M. Smith sold 215 shares of the business’s stock in a transaction dated Tuesday, August 20th. The stock was sold at an average price of $493.18, for a total transaction of $106,033.70. Following the transaction, the director now owns 330,868 shares in the company, valued at $163,177,480.24. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, COO Salvatore Brogna sold 1,171 shares of the business’s stock in a transaction dated Tuesday, September 3rd. The stock was sold at an average price of $505.23, for a total value of $591,624.33. Following the transaction, the chief operating officer now owns 5,933 shares in the company, valued at approximately $2,997,529.59. The disclosure for this sale can be found here. Insiders have sold 25,869 shares of company stock valued at $13,664,252 in the last three months. 1.70% of the stock is currently owned by company insiders.

Intuitive Surgical Profile

Intuitive Surgical, Inc designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. Its da Vinci Surgical System transforms the surgeon's natural hand movements outside the body into corresponding micro-movements inside the patient's body. The company's da Vinci Surgical System include surgeon's consoles, patient-side carts, 3-D vision systems, da Vinci skills simulators, da Vinci Xi integrated table motions, and Firefly fluorescence imaging products that enable surgeons to perform various surgical procedures, including gynecologic, urologic, general, cardiothoracic, and head and neck surgical procedures.

Recommended Story: Moving Average – How it Helps Investors in Stock Selection

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG).

Institutional Ownership by Quarter for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.